Attitudes and practice in the management of metastatic colorectal cancer in Britain

Clinical Oncology

Volumn 9, Issue 4, 1997, Pages 248-251

  Seymour, M T ^a   Stenning, S P ^b   Cassidy, J ^c  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Advanced colorectal cancer; Chemotherapy; Evidence based medicine

Indexed keywords

ARTICLE; ATTITUDE; CLINICAL PRACTICE; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; EVIDENCE BASED MEDICINE; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030881538     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0936-6555(97)80010-6     Document Type: Article

References (16)

1. Cancer Research Campaign. Factsheets 3.2-3.3 (UK cancer statistics). London: CRC, 1995.
2. Seymour MT, Slevin ML, Kerr DJ, et al., for the Colorectal Cancer Working Party of the MRC. A randomized trial assessing the addition of interferon α2a to 5-fluorouracil and leucovorin in advanced colorectal cancer. J Clin Oncol 1996;14:2280-8.
3. Scheele J, Stang R, Altendorf-Hofmann A, et al. Resection of colorectal liver metastases. World J Surg 1995;19:59-71.
4. Scheithauer W, Rosen H, Kornek GV, et al. Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. BMJ 1993;306:752-5.
5. Nordic Gastrointestinal Tumour Adjuvant Therapy Group. Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial. J Clin Oncol 1992;10:904-11.
6. Beretta G, Bollina R, Martignoni M, et al. Fluorouracil + folates as standard treatment for advanced/metastatic gastrointestinal carcinomas [abstract]. Ann Oncol 1994;5(Suppl 8): P239.
7. Allen-Mersh TG, Earlam S, Fordy C, et al. Quality of life and survival with continuous hepatic artery floxuridine infusion for colorectal liver metastases. Lancet 1994;344:1255-60.
8. Maynard A. Evidence-based medicine: an incomplete method for informing treatment choices. Lancet 1997;349:126-8.
9. Agency for Health Care Policy and Research. Acute pain management: operative or medical procedures and trauma. (92-0032) (Clinical Practice Guideline). Bethesda: National Institutes of Health, 1992.
10. Lokich J, Ahlgren J, Gullo J, et al. A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma. J Clin Oncol 1989;7:425-32.
11. Johnson PMW, Thompson PI, Seymour MT, et al. A less toxic regimen of 5-fluorouracil and high dose folinic acid for gastrointestinal adenocarcinomas. Br J Cancer 1991;64:603-5.
12. De Gramont A, Bosset JF, Milan C, et al. A prospectively randomised trial comparing 5FU bolus with low dose folinic acid and 5FU bolus plus continuous infusion with high dose folinic acid for advanced colorectal cancer [abstract]. Proc ASCO 1995;14:194.
13. Advanced Colorectal Cancer Meta-analysis Project. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. J Clin Oncol 1992;10:896-903.
14. Chemotherapy choices in colorectal cancer (CR06): a randomised trial comparing 2 durations and 3 systemic chemotherapy regimens in the palliative treatment of advanced colorectal cancer. UK Medical Research Council, Colorectal Cancer Working Party. Clinical Protocol, February 1996.
15. Scottish Intercollegiate Guidelines Network (SIGN). Guidelines on best current practice for colorectal cancer. Edinburgh: Scottish Cancer Therapy Network/Scottish Cancer Coordinating and Advisory Committee, 1997 (in press).
16. A policy framework for commissioning cancer services: a report by the Expert Advisory Group on Cancer to the Chief Medical Officers of England and Wales. London: Department of Health, 1995.